Review
Copyright ©The Author(s) 2015.
World J Hepatol. Jun 28, 2015; 7(12): 1606-1616
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1606
Table 3 Treatment of liver transplant candidates with hepatitis C[6]
Cirrhosis CP A, all HCV genotypes
Sofosbuvir + RBV until LTPeg-IFN + RBV + sofosbuvir for 12 wkRBV + sofosbuvir + daclatasvir for 12 wk
Cirrhosis CP B and C, all HCV genotypes
Sofosbuvir + RBV until LTIFN contraindicatedRBV + sofosbuvir + daclatasvir for 12 wk